Robert Coury - Viatris Chairman

Chairman

Mr. Robert J. Coury has served as NonExecutive Chairman of the Board of Mylan N.V. since June 3, 2016. Under his visionary leadership, Mylan has transformed from the third largest generics pharmaceutical company in the U.S. into one of the largest pharmaceutical companies in the world in terms of revenue, earning spots in both the SP 500 and, prior to the Companys reincorporation outside of the U.S. in 2015, the Fortune 500 since 2016.
Age 57
Tenure 8 years
Phone44 1707 853 000
Webhttp://www.mylan.com
Coury was first elected to the Mylan Board in February 2002, having served since 1995 as a strategic advisor to the Company. He became the Mylan Board’s Vice Chairman shortly after his election and served as CEO from September 2002 until January 2012, and as Executive Chairman from 2012 until he became Chairman as a director who is not an employee of the Company or Mylan Inc. in June 2016. Since 2007, Mr. Coury has led the Company through a series of transactions totaling approximately $25 billion, which transformed Mylan into a global powerhouse within the highly competitive pharmaceutical industry, with a global workforce of over 35, 000 and products sold in more than 165 countries. In 2007, Mylan purchased Indiabased Matrix Laboratories Limited, a major producer of active pharmaceutical ingredients, and the generics and specialty pharmaceuticals business of Europebased Merck KGaA. Subsequent acquisitions under Mr

Viatris Management Efficiency

The company has Return on Asset of 3.63 % which means that on every $100 spent on assets, it made $3.63 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 2.22 %, implying that it generated $2.22 on every 100 dollars invested. Viatris' management efficiency ratios could be used to measure how well Viatris manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 12.51 B in debt with debt to equity (D/E) ratio of 1.0, which is OK given its current industry classification. Viatris has a current ratio of 0.99, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist Viatris until it has trouble settling it off, either with new capital or with free cash flow. So, Viatris' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Viatris sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Viatris to invest in growth at high rates of return. When we think about Viatris' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 8 records

CHAIRMAN Age

Alfred WestSEI Investments
81
Jerold RubinsteinUS Global Investors
77
Najeeb GhauriNetSol Technologies
70
William DoranSEI Investments
83
Roy TerracinaUS Global Investors
69
Guy BernsteinSapiens International
49
Benjamin SilbermannPinterest
41
Thomas LydonUS Global Investors
56
Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded-generic, brand-name, and over-the-counter pharmaceutical products in North America, Europe, and internationally. The company was founded in 1961 and is based in Hatfield, the United Kingdom. Mylan NV operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 35000 people. Viatris (MYL) is traded on NASDAQ Exchange in USA and employs 35,000 people.

Management Performance

Viatris Leadership Team

Elected by the shareholders, the Viatris' board of directors comprises two types of representatives: Viatris inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Viatris. The board's role is to monitor Viatris' management team and ensure that shareholders' interests are well served. Viatris' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Viatris' outside directors are responsible for providing unbiased perspectives on the board's policies.
Anthony Mauro, President of Mylan North America
Joseph Maroon, Independent Director
Kris King, VP of Global Investor Relations
Heather Bresch, CEO, Executive Director and Member of Science and Technology Committee
Harry Korman, Non-Executive Independent Director
Melina Higgins, Independent Director
Mark Parrish, Independent Director
Kenneth Parks, CFO
Rodney Piatt, Vice Chairman of the Board, Lead Independent Director
Rajiv Malik, President, Executive Director and Member of Science and Technology Committee
John Sheehan, Executive Vice President CFO, Principal Financial officer
Dennis Zeleny, Chief Human Resource Officer
JoEllen Dillon, Independent Director
Neil Dimick, Independent Director
Sjoerd Vollebregt, Independent Director
Douglas Leech, Independent Director
Robert Cindrich, Independent Director
Pauline Mohr, Non-Executive Independent Director
Wendy Cameron, Independent Director
Rakesh Bamzai, President - India Commercial and Emerging Markets
Robert Coury, Executive Chairman and Chairman of Executive Committee
Daniel Gallagher, Chief Legal Officer
Richard Mark, Non-Executive Independent Director
Randall Vanderveen, Independent Director

Viatris Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Viatris a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Viatris in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Viatris' short interest history, or implied volatility extrapolated from Viatris options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Consideration for investing in Viatris Stock

If you are still planning to invest in Viatris check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Viatris' history and understand the potential risks before investing.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites